Clinical outcomes in patients with psoriasis following discontinuation of efalizumab due to suspension of marketing authorization - Baniandrés, O.; Pulido, A.; Silvente, C.; Suárez, R.; Lázaro, P (Actas Dermosifiliogr, 2010)